Código QR (código de barras bidimensional)

Anti-MET Antibody Therapies in Non-Small-Cell Lung Cancer: Current Progress and Future Directions

<b>Background/Objectives:</b> Non-small-cell lung cancer (NSCLC) remains a leading cause of cancer mortality globally, though advances in targeted therapies have improved treatment outcomes. The mesenchymal–epithelial transition (<i>MET</i>) gene plays a significant role in NSCLC, often through prot...

ver descrição completa

Na minha lista:
Principais autores: Kinsley Wang, Robert Hsu
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2024-10-01
coleção:Antibodies
Assuntos:
MET (mesenchymal–epithelial transition factor)
NSCLC (non-small-cell lung cancer)
EGFR-mutated NSCLC
targeted therapies
amivantamab
Acesso em linha:https://www.mdpi.com/2073-4468/13/4/88
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados